PNPLA3 and metabolic dysfunction-associated steatotic liver disease: A roadblock to identifying potential treatments for PNPLA3-induced NAFLD is the lack of a cellular platform that recapitulates PNPLA3 (I148M)-mediated onset of lipid accumulation in human hepatocytes.